.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Fade Co. is stocked at 175 licensed dispensaries across Maryland, Arizona, and 2 other states, 107 of them in Maryland, with the deepest coverage in Baltimore, Silver Spring, Annapolis, Columbia, and Hagerstown. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, Fade Co.'s mix skewed heavily to Flower at 76.87% share with year-over-year growth of 18.66% and month-over-month growth of 7.05%, while Vapor Pens held 7.51% share with a -20.51% year-over-year change but a 7.60% month-over-month lift. Pre-Roll accounted for 10.98% share with a -15.42% year-over-year shift and a 17.05% month-over-month rise, as Concentrates and Edible, at 3.54% and 1.10% share respectively, posted sharp month-over-month gains of 24.55% and 57.14% amid limited year-over-year baselines. With average price up 16.74% year over year and overall brand sales up 14.67% year over year, this mix points to a Flower-led recovery bolstered by short-cycle rebounds in smaller categories, implying price-led expansion concentrated in core inhalables.
These shifts suggest Fade Co. is consolidating its position around high-velocity Flower while rebuilding trial in ancillary formats, with Concentrates’ 24.55% month-over-month and Edible’s 57.14% month-over-month gains indicating incremental reach rather than a reallocation away from Flower’s 76.87% anchor share. The -20.51% year-over-year decline in Vapor Pens alongside a 7.60% month-over-month uptick, coupled with Pre-Roll’s -15.42% year-over-year but 17.05% month-over-month pattern, implies elasticity-driven, promotion-responsive demand that can be timed to smooth seasonality without eroding the core; in Maryland Flower at rank 3 provides the platform to test price and pack architecture across adjacent formats.
Competitive Landscape
Fade Co. sits at rank #3 in MD Flower in July 2026, down one position year over year from #2, and also down one spot versus April 2026 when it held #2; this slippage comes despite the category’s top end tightening, with SunMed holding #1 (up 7.8% YoY in sales) and RYTHM advancing from #3 to #2 on 47.9% YoY sales growth, while District Cannabis improved from #5 to #4 with 19.0% YoY growth. Fade Co.’s peak at #1 back in December 2024 contrasts with Strane rising from #8 to #5 on 82.3% YoY growth, indicating competitive share is migrating toward faster-growing rivals and that Fade Co.’s current rank trajectory implies a need to defend against momentum brands to avoid further rank loss.
Notable Products
E85 Candi A (3.5g) posted the largest month-over-month move in July 2026 at +58.7% while climbing to rank 3, whereas Mule Fuel (3.5g) fell 12.8% and sat at rank 8, indicating divergence within the Flower lineup. Super Boof (3.5g) held rank 1 with a 7.2% MoM lift, and four of the top ten are Flower SKUs concentrated in the top eight ranks, which tilts the portfolio mix toward higher-tier inhalables. With Pre-Rolls occupying ranks 4 through 5 and 7 through 10 but lacking double-digit MoM gains, the mix points to Flower as the current growth engine while Pre-Rolls function as volume stabilizers rather than growth drivers.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
